Wittenberg Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Wittenberg Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-229,000	Closed	-$48.3K	–	88
2023 Q2	$48.3K	Buy	229,000 +57,000	+33%	+$9.9K	0.02%	85
2023 Q1	$27.5K	Buy	+172,000	New	+$76.4K	0.01%	86

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Wittenberg Investment Management's INFI Position: Q3 2023 in Review

Wittenberg Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 229,000 shares — an estimated $48.3K sold.

Wittenberg Investment Management first reported a position in INFI in Q1 2023 and held it in 2 quarters. The position peaked at $48.3K in Q2 2023. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Wittenberg Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Wittenberg Investment Management sold 229,000 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $48.3K.
Wittenberg Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2023 and held it in 2 quarters.
Wittenberg Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $48.3K in Q2 2023.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Wittenberg Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.